EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mesenchymal stem cells ( MSCs ) and MSC ‐derived exosomes in animal models of central nervous system diseases: Targeting the NLRP3 inflammasome

Shahrzad Nazari iD, Seyed Mahmoud Pourmand iD, Elahe Motevaseli iD, Gholamreza Hassanzadeh iD

IUBMB Life · 2023

DOI: 10.1002/iub.2759 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift IUBMB Life, 2023. Verfasst von Shahrzad Nazari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Exosomes, Central Nervous System Diseases, Mesenchymal Stem Cells. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 202 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NLRP3 (NOD‐, LRR‐, and pyrin domain‐containing protein 3) inflammasome is a multimeric protein complex that is engaged in the innate immune system and plays a vital role in inflammatory reactions. Activation of the NLRP3 inflammasome and subsequent release of proinflammatory cytokines can be triggered by microbial infection or cellular injury. The NLRP3 inflammasome has been implicated in the pathogenesis of many disorders affecting the central nervous system (CNS), ranging from stroke, traumatic brain injury, and spinal cord injury to Alzheimer's disease, Parkinson's disease, epilepsy, multiple sclerosis, and depression. Furthermore, emerging evidence has suggested that mesenchymal stem cells (MSCs) and their exosomes may modulate NLRP3 inflammasome activation in a way that might be promising for the therapeutic management of CNS diseases. In the present review, particular focus is placed on highlighting and discussing recent scientific evidence regarding the regulatory effects of MSC‐based therapies on the NLRP3 inflammasome activation and their potential to counteract proinflammatory responses and pyroptotic cell death in the CNS, thereby achieving neuroprotective impacts and improvement in behavioral impairments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesCentral Nervous System DiseasesMesenchymal Stem CellsAnimalsInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinModels, Animal

Stichwörter der Autor:innen

CNS diseasesNLRP3exosomesinflammasomesmesenchymal stem cellsneuroinflammation

Substanzen

InflammasomesNLR Family, Pyrin Domain-Containing 3 Protein

Autor:innen und Institutionen

  • Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Shahrzad Nazari, Seyed Mahmoud Pourmand, Elahe Motevaseli, Gholamreza Hassanzadeh

Zitieren

APA

Nazari, S., Pourmand, S. M., Motevaseli, E., & Hassanzadeh, G. (2023). Mesenchymal stem cells ( MSCs ) and MSC ‐derived exosomes in animal models of central nervous system diseases: Targeting the NLRP3 inflammasome. IUBMB Life. https://doi.org/10.1002/iub.2759

Vancouver

Nazari S, Pourmand SM, Motevaseli E, Hassanzadeh G. Mesenchymal stem cells ( MSCs ) and MSC ‐derived exosomes in animal models of central nervous system diseases: Targeting the NLRP3 inflammasome. IUBMB Life. 2023. doi:10.1002/iub.2759

BibTeX
@article{Nazari2023,
  author = {Nazari, Shahrzad and Pourmand, Seyed Mahmoud and Motevaseli, Elahe and Hassanzadeh, Gholamreza},
  title = {Mesenchymal stem cells ( MSCs ) and MSC ‐derived exosomes in animal models of central nervous system diseases: Targeting the NLRP3 inflammasome},
  journal = {IUBMB Life},
  year = {2023},
  doi = {10.1002/iub.2759}
}
Kostenlos starten →